MYCELA LABS AS
Under liquidation: 01/06/2026, Voluntary liquidation
Bioteknologi med fokus på mycelium (sopp). Utvikling og produksjon av
produkter av mycelium og andre bioteknologiske materialer.
Utvikling, produksjon, og salg av biomaterialer (deriblant mycelium).
Organization
- Chairman of the board
- SE
Sondre Eng1993
- Years since formation
- 3 years
- since Jan 2, 2023
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 32,273
- 1 share class
- Total number of shareholders
- 10
- 9 companies, 1 person
Financials
- Total operating income 2025
- 543,056
- NOK
- Annual total result 2025
- -282,095
- NOK
- Total equity 2025
- 174,740
- NOK
Last update: May 20, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
SE 1993 | Chairman | 29.59 % indirectly |
RI | Board Member | 33.31 % indirectly |
NH 1988 | Board Member | 29.59 % indirectly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
RI | Board Member | 33.31 % indirectly |
NH 1988 | Board Member | 29.59 % indirectly |
SE 1993 | Chairman | 29.59 % indirectly |
BM 1995 | - | 2.32 % indirectly |
| - | 2.32 % indirectly |
Last update: Dec 4, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 10,750 | 33.31 % | |
| Ordinary shares | 9,550 | 29.59 % | |
| Ordinary shares | 9,550 | 29.59 % | |
| Ordinary shares | 1,500 | 4.65 % | |
PF | Ordinary shares | 216 | 0.67 % |
| Ordinary shares | 215 | 0.67 % | |
| Ordinary shares | 150 | 0.46 % | |
| Ordinary shares | 126 | 0.39 % | |
| Ordinary shares | 108 | 0.33 % | |
| Ordinary shares | 108 | 0.33 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total operating income | 543,056 | 964,293 | 65,461 |
Annual Total Result | -282,095 | -256,209 | -378,450 |
Total assets | 275,598 | 604,842 | 770,045 |
Total liabilities | 100,858 | 148,008 | 1,017,621 |
Total equity | 174,740 | 456,835 | -247,577 |
P&L
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total operating income | 543,056 | 964,293 | 65,461 |
Total operating costs | 824,628 | 1,220,222 | 443,465 |
Operating result | -281,572 | -255,929 | -378,004 |
Financial income/costs | -523 | -280 | -446 |
Profit before tax | -282,095 | -256,209 | -378,450 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -282,095 | -256,209 | -378,450 |
Balance overview
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total fixed assets | 111,646 | 125,171 | 36,564 |
Total current assets | 163,952 | 479,671 | 733,481 |
Total assets | 275,598 | 604,842 | 770,045 |
Short term debt | 100,858 | 148,008 | 1,017,621 |
Long term debt | 0 | 0 | 0 |
Total liabilities | 100,858 | 148,008 | 1,017,621 |
Contributed capital | 1,091,494 | 1,091,494 | 130,872 |
Retained earnings | -916,754 | -634,659 | -378,449 |
Total equity | 174,740 | 456,835 | -247,577 |
Total equity and liabilities | 275,598 | 604,843 | 770,044 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises